Nomura Holdings Inc ADR(NMR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 12.61 | EPS (ttm) | 0.86 | Insider Own | - | Shs Outstand | 2.92B | Perf Week | 2.26% |
| Market Cap | 31.74B | Forward P/E | 11.37 | EPS next Y | -0.22% | Insider Trans | - | Shs Float | 2.92B | Perf Month | 9.59% |
| Enterprise Value | 238.96B | PEG | 1.38 | EPS next Q | 0.23 | Inst Own | 3.03% | Short Float | 0.05% | Perf Quarter | 24.97% |
| Income | 2.60B | P/S | 0.99 | EPS this Y | 23.83% | Inst Trans | 0.42% | Short Ratio | 1.41 | Perf Half Y | 44.99% |
| Sales | 32.18B | P/B | 1.35 | EPS next 5Y | 8.24% | ROA | 0.63% | Short Interest | 1.37M | Perf YTD | 29.44% |
| Book/sh | 8.07 | P/C | 0.93 | EPS past 3/5Y | 51.38% 10.83% | ROE | 10.93% | 52W High | 0.65% ($10.79) | Perf Year | 43.84% |
| Cash/sh | 11.66 | P/FCF | - | Sales past 3/5Y | 19.88% 15.72% | ROIC | 1.73% | 52W Low | 61.85% ($6.71) | Perf 3Y | 158.57% |
| Dividend Est. | $0.39 (3.58%) | EV/EBITDA | 55.57 | EPS Y/Y TTM | 4.45% | Gross Margin | 40.28% | Volatility(W/M) | 1.6% 1.28% | Perf 5Y | 108.45% |
| Dividend TTM | 0.47 | EV/Sales | 7.42 | Sales Y/Y TTM | 2.94% | Oper. Margin | 11.86% | ATR (14) | 0.21 | Perf 10Y | 132.55% |
| Dividend Ex-Date | 2026/3/31 | Quick Ratio | 1.41 | EPS Q/Q | 28.83% | Profit Margin | 8.09% | RSI (14) | 71.26 | Recom | 2.1 |
| Dividend Gr. 3/5Y | 42.6% - | Current Ratio | 1.41 | Sales Q/Q | 7.6% | SMA20 | 7.29% ($10.12) | Beta | 0.75 | Target Price | $10.7 |
| Payout | 36.75% | Debt/Eq | 10.19 | Earnings | 2026/7/29 | SMA50 | 10.13% ($9.86) | Rel Volume | 0.9 | Prev Close | $10.54 |
| Employees | 28677 | LT Debt/Eq | 5.38 | EPS/Sales Surpr. | 31.76% 23.34% | SMA200 | 23.98% ($8.76) | Avg Volume(3M) | 0.98M | Price | $10.86 |
| IPO | 2001/12/17 | Option/Short | Yes/Yes | Trades | 3890 | Volume | 883,623 | Change | 3.04% |
Company
NMR is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A comprehensive financial group headquartered in Japan, this is a leading Japanese securities and investment banking stock listed as an ADR. It delivers investment banking, global markets, asset management, and wealth management services to global markets. It trades on U.S. exchanges in ADR form and maintains a multi-regional business network spanning Japan, Asia, the U.S., and Europe.
Over the past 1 year, on the higher side
0% below its 1-year high.
NMR has weak earning power
11.86% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +23.8% this year.
Tap to view numbers
The price looks about right
Trading at 12.6 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +158.6% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 3.58% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 3.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $32B.
FAQ
What kind of company is NMR?
NMR belongs to the Financial sector and operates in the Capital Markets industry.
What is the market cap of NMR?
The market cap of NMR is approximately $31.7B, ranking 452 within its sector.
Does NMR pay dividends?
NMR has a dividend yield of approximately 3.58%, with an annual dividend of $0.39.
What is the P/E ratio of NMR?
NMR has a P/E ratio of approximately 12.6x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for NMR?
NMR has recorded a 52-week high of $10.79 and a low of $6.71.